Oriola-KD Corporation

1 Abonnés

Oriola-KD has a solid position in consumer and services business in the pharmaceutical markets in Sweden, Finland and Baltic countries. Oriola-KD offers expert advice on health and wellbeing and an extensive and high-quality selection of products in its own pharmacies. To healthcare operators, Oriola-KD provides wide service offering covering pharmaceutical distribution, branded products and other tailored services. Oriola-KD’s net sales for continuing operations in 2016 were approximately EUR 1.6 billion. Company has approximately 2,821 employees. Oriola-KD is listed on NASDAQ OMX Helsinki Ltd. For more information, visit www.oriola-kd.com.

oriola oriola-kd yritysesite company brochure vuosikertomus toimintakertomus tilinpaatos terveydenhuolto annual report financial statements healthcare investor relations financial report q4 carnegie vuosikooste investor presentation

Tout plus

Activité
À propos

Oriola-KD Corporation

Présentations

Presentation: Sale of Oriola-KD Russian operations 8 December 2014

Oriola-KD Annual Review 2014

Presentation Oriola-KD’s Financial Statements for 2014

Carnegie Healthcare Seminar 12 March 2015

Oriola-KD:n vuosikooste 2014

Investor presentation Result 2015

Oriola-KD Annual Report 2016

Oriola-KD: vuosikertomus 2016

Documents

Oriola-KD Annual review 2015

Oriola KD:n vuosikooste 2015

Oriola-KD:n yritysesite 2016

Oriola-KD Company Brochure 2016